pills

Rare Disease patient advocates & Orphan drug developers joining BioPharma Asia 2016

Emily Event News Leave a Comment

The World Orphan Drug Congress Asia is now a part of the 9th Biopharma Asia Convention. Pharma, government representatives and rare disorder patient advocates will now be gathered under the same roof to discuss on strategies to cater to the needs of minorities by building a more transparent orphan drug policies in Asia. Asia Pacific Alliance of Rare Disorders Organisations (APARDO), …

Join us at BioPharma Asia Convention 2016 
Clinical trials| Manufacturing| Supply Chain| Partnering| Vaccines| Infectious diseases| Biosimilars| Antibodies| Orphan drugs

Meet supply chain and trade regulation experts at BioPharma Asia Convention 2016

Emily Event News Leave a Comment

The lack of coherent supply chain regulation and trade practices remains the major challenge for pharma supply chain personnel in Asia. To make sure that your approved biologics drugs can be distributed to your local destination, you need to meet the right regulators and experts to optimise your supply chain practices. That’s why you should join us at BioPharma Asia. …

Photo with Dr Ajith Kamath(from left), Dr Renu Swarup, Dr Kaushik Deb, Mr Narasimha Rao, and Dr BN Manohar
Taken at BioPharma India Convention 2015, 3-4 November, Mumbai, India

Quick recap of 13th BioPharma India Convention, Mumbai

Emily Event News Leave a Comment

Photo with Dr Ajith Kamath(from left), Dr Renu Swarup, Dr Kaushik Deb, Mr Narasimha Rao, and Dr BN Manohar Taken at BioPharma India Convention 2015, 3-4 November, Mumbai, India According to IMS Health Asia Pacific, the following 10 companies were ranked to capture near 50% of the entire India pharma market share: Sun Pharma Abbott Cipla Mankind Zydus Cadila GSK Alkem …

Clinial trials| Manufacturing| Supply Chain| Partnering| Orphan drugs| Biosimilars| Antibodies| Vaccines | Infectious diseases

Top 5 reasons why you should join us at BioPharma Asia Convention

Emily Event News Leave a Comment

As you know, clinical development is a critical but lengthy part of the drug development process, as it determines the efficacy of a drug candidate in treating disease. When it takes an average of 10-15 years to push a drug candidate from lab discovery to regulatory approval, it is absolutely critical for clinical personnel to understand the best way to …